Flow diagram of participants meeting the inclusion and exclusion criteria. by Yeo Ju Sohn (18536198)

Subjects:

Initial participants by wave*. by Yeo Ju Sohn (18536198)

Subjects:

These files contain the STATA program codes used in the study. by Yeo Ju Sohn (18536198)

Subjects:

Generalized estimating equation model covariance structure analysis. by Yeo Ju Sohn (18536198)

Subjects:

Raw dataset collected from the KLoSA from 2006 to 2020. by Yeo Ju Sohn (18536198)

Subjects:

General characteristics of research participants. by Yeo Ju Sohn (18536198)

Subjects:

Generalized estimation equation model analysis of diabetes mellitus incidence according to relative handgrip strength. by Yeo Ju Sohn (18536198)

Subjects:

Trends analysis in diabetes mellitus diagnosis according to relative handgrip strength. by Yeo Ju Sohn (18536198)

Subjects:

Receptivity of virgin and mated females after seminal fluid protein candidate genes were knocked down by dsRNA injections, scored as the percentage of females that copulated within... by Yi-Jie Zhang (713506)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Estimated coefficients from the SARIMA model of new COVID-19 deaths assuming a gradual effect following the implementation of two ETSs and one executive order in Oregon. by Raul Cruz-Cano (3751321)

Subjects:

Trends in COVID-19 deaths in Oregon, for both the overall population and by agricultural worker type, between March 1, 2020 and February 27, 2021. by Raul Cruz-Cano (3751321)

Subjects:

Correlation between the 7-day rolling average of estimated new daily COVID-19 cases among agricultural labor groups and the general population in Oregon. by Raul Cruz-Cano (3751321)

Subjects:

Estimated coefficients from the SARIMA model of new COVID-19 cases, assuming an abrupt effect following the implementation of two ETSs and one executive order in Oregon. by Raul Cruz-Cano (3751321)

Subjects:

Trends in COVID-19 cases in Oregon, for both the overall population and by agricultural worker type, between March 1, 2020 and February 27, 2021. by Raul Cruz-Cano (3751321)

Subjects:

Estimated number of COVID-19 cases and deaths among various types of agricultural workers in Oregon from March 1, 2020, to February 27, 2021. by Raul Cruz-Cano (3751321)

Subjects:

EM wave propagation model in porous media of goaf. by Qingsong Zhang (3353270)

Subjects:

Signal intensity curves at 0.2 and 0.4 porosity. by Qingsong Zhang (3353270)

Subjects: